ClinicalTrials.Veeva

Menu
M

Maple Leaf Research | Toronto, Canada

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Emtricitabine
TDF
Tenofovir Alafenamide
Rilpivirine
TAF
FTC
Bictegravir
RPV
Doravirine
Tenofovir Disoproxil Fumarate

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 18 total trials

Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with semaglutide in participants with Type 2 Diabetes and...

Enrolling
Diabetes Mellitus, Type 2
Drug: Retatrutide
Drug: Semaglutide

The safety and tolerability of MK-8591A, a 2-drug fixed dose combination (FDC) of doravirine (DOR 100mg) and islatravir (ISL 0.75mg) will be evaluate...

Active, not recruiting
HIV-1 Infection
Drug: MK-8591A

This study will evaluate the safety and efficacy of a switch to MK-8591A (a fixed dose combination of doravirine and islatravir) in human immunodefic...

Active, not recruiting
HIV Infection
Drug: ART
Drug: DOR/ISL

The goal of this clinical study is to learn more about the effects of switching to the study drugs, bictegravir (BIC) plus lenacapavir (LEN), versus...

Enrolling
HIV-1-infection
Drug: Stable Baseline Regimen
Drug: Bictegravir

Trial sponsors

Gilead Sciences logo
U
Merck Sharp & Dohme (MSD) logo
Lilly logo
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems